INT278361

From wiki-pain
Revision as of 13:40, 23 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.41
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 6
Total Number 6
Disease Relevance 0.63
Pain Relevance 0.15

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (Lyn) Golgi apparatus (Lyn) plasma membrane (Lyn)
nucleus (Lyn) enzyme binding (Lyn) kinase activity (Lyn)
Anatomy Link Frequency
C8-B4 2
Lyn (Mus musculus)
Pain Link Frequency Relevance Heat
Potency 26 92.08 High High
Glutamate 2 75.16 Quite High
gABA 2 74.36 Quite High
imagery 14 63.96 Quite High
rheumatoid arthritis 1 24.64 Low Low
cytokine 13 9.76 Low Low
antidepressant 70 5.00 Very Low Very Low Very Low
Endep 32 5.00 Very Low Very Low Very Low
Neuropathic pain 18 5.00 Very Low Very Low Very Low
antagonist 12 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Fever 9 77.48 Quite High
Colitis 1 76.68 Quite High
Cytomegalovirus Infection 1 75.80 Quite High
Pneumonia 1 75.60 Quite High
Pleural Effusion 20 75.08 Quite High
Lymphocytosis 2 70.92 Quite High
Cancer 17 58.88 Quite High
Leukemia 39 50.00 Quite Low
Systemic Lupus Erythematosus 1 47.96 Quite Low
Myeloid Leukemia 197 46.00 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Other mechanisms of imatinib resistance may include: increased expression of Bcr-Abl through genomic amplification (Nicolini et al 2006), overexpression of Lyn or other Src-family tyrosine kinases (Donato et al 2003; Dai et al 2004), or overexpression of drug efflux proteins such as P-glycoprotein, which may decrease the intracellular concentration of imatinib in leukemic cells (Thomas et al 2004).
Positive_regulation (increased) of Gene_expression (overexpression) of Lyn
1) Confidence 0.41 Published 2008 Journal Drug design, development and therapy Section Body Doc Link PMC2761189 Disease Relevance 0.06 Pain Relevance 0
Other mechanisms of imatinib resistance may include: increased expression of Bcr-Abl through genomic amplification (Nicolini et al 2006), overexpression of Lyn or other Src-family tyrosine kinases (Donato et al 2003; Dai et al 2004), or overexpression of drug efflux proteins such as P-glycoprotein, which may decrease the intracellular concentration of imatinib in leukemic cells (Thomas et al 2004).
Positive_regulation (overexpression) of Gene_expression (overexpression) of Lyn
2) Confidence 0.27 Published 2008 Journal Drug design, development and therapy Section Body Doc Link PMC2761189 Disease Relevance 0.06 Pain Relevance 0
We measured elevated levels of Lyn tyrosine kinase in activated C8-B4 cells.
Positive_regulation (elevated) of Gene_expression (levels) of Lyn tyrosine kinase in C8-B4
3) Confidence 0.25 Published 2010 Journal The Journal of General Physiology Section Body Doc Link PMC2847917 Disease Relevance 0 Pain Relevance 0.11
Altogether, these results reveal that Lyn/Syk activation following Hz exposure initiates the PI3K and ERK signaling pathways and these pathways appear to regulate the production of mature IL-1?.
Positive_regulation (activation) of Gene_expression (exposure) of Lyn
4) Confidence 0.24 Published 2009 Journal PLoS Pathogens Section Body Doc Link PMC2722371 Disease Relevance 0 Pain Relevance 0
Copy number for each molecule (all P2X subunits and Lyn tyrosine kinase) was determined based on comparisons to standard curves, and for each sample, the copy number for each molecule was normalized to the expression of the endogenous housekeeping gene hypoxanthine phosphoribosyl transferase (HPRT).


Positive_regulation (normalized) of Gene_expression (expression) of Lyn tyrosine kinase
5) Confidence 0.18 Published 2010 Journal The Journal of General Physiology Section Body Doc Link PMC2847917 Disease Relevance 0 Pain Relevance 0
These include upregulation of the ABCB1 or ABCG2 drug efflux pumps,58,63,64 downregulation of human organic cation transporter 1 (hOCT1) drug influx transporters,65,66 overexpression of Lyn, a Src-family kinase,67 and other Bcr-Abl-independent mechanisms.
Positive_regulation (overexpression) of Gene_expression (overexpression) of Lyn
6) Confidence 0.18 Published 2009 Journal OncoTargets and therapy Section Body Doc Link PMC2886328 Disease Relevance 0.52 Pain Relevance 0.05

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox